§ 161 to 165. — Omitted.
[Laws in effect as of January 24, 2002]
[Document not affected by Public Laws enacted between
January 24, 2002 and December 19, 2002]
[CITE: 21USC161]
TITLE 21--FOOD AND DRUGS
CHAPTER 5A--BUREAU OF NARCOTICS
Secs. 161 to 165. Omitted
Codification
Section 161, acts June 14, 1930, ch. 488, Sec. 1, 46 Stat. 585; Oct.
15, 1949, ch. 695, Sec. 6(a), 63 Stat. 881, established a Bureau of
Narcotics in the Department of the Treasury and provided for appointment
of a Commissioner of Narcotics for the Bureau with duty of making an
annual report to Congress.
Section 162, acts June 14, 1930, ch. 488, Sec. 2, 46 Stat. 585; June
26, 1930, ch. 623, Sec. 1, 46 Stat. 819; Oct. 27, 1970, Pub. L. 91-513,
title III, Sec. 1101(a)(4), 84 Stat. 1291, provided for appointment and
compensation of a deputy commissioner and other personnel for the Bureau
of Narcotics, required the deputy to be an acting Commissioner during
absence or disability of the Commissioner or a vacancy in the office,
and authorized designation of a member of the Treasury Department as an
acting Commissioner in event there is no Commissioner or deputy
commissioner.
Section 163, act Mar. 3, 1927, ch. 348, Sec. 4(a), 44 Stat. 1382,
provided for transfer of control of narcotic drugs to the Secretary of
the Treasury from the Commissioner of Internal Revenue and his
assistants, agents, and inspectors.
Section 164, acts June 14, 1930, ch. 488, Sec. 3, 46 Stat. 586; June
26, 1930, ch. 623, Sec. 2, 46 Stat. 819; Ex. Ord. No. 6639, Mar. 10,
1934, abolished the Federal Narcotics Control Board and transferred
powers of such Board to the Commissioner of Narcotics, authorized the
Secretary of the Treasury to confer or impose his duties under section
163 of this title upon the Commissioner or other personnel of the Bureau
of Narcotics, continued in effect orders, rules, and regulations in
existence on July 1, 1930, until modified, superseded, or repealed by
the Commissioner, with approval of the Secretary of the Treasury, and
provided for determination before such Bureau of Narcotics of
proceedings, investigations, and other matters pending on July 1, 1930
before Bureau of Prohibition or Federal Narcotics Control Board
respecting narcotic drug law administration or enforcement. Bureau of
Prohibition personnel, records, property, and unexpended balances of
appropriations were previously transferred to Bureau of Narcotics as
were powers of the Attorney General respecting the Bureau of Prohibition
to the Commissioner of Internal Revenue.
Section 165, act June 14, 1930, ch. 488, Sec. 5, 46 Stat. 587,
provided for review of decisions of Commissioner of Narcotics by the
Secretary of the Treasury.
Transfer of Functions
Functions of the Secretary of the Treasury administered through or
respecting the Bureau of Narcotics and all functions of the Bureau, the
Commissioner of Narcotics, and the officers, employees and agencies of
the Bureau were transferred to the Attorney General and the Bureau and
the office of Commissioner of Narcotics were abolished by Reorg. Plan
No. 1 of 1968, eff. Apr. 8, 1968, 33 F.R. 5611, 82 Stat. 1367, set out
in the Appendix to Title 5, Government Organization and Employees. All
positions, personnel, property, records, and unexpended balances of
appropriations, allocations, and other funds of the Bureau and the
Treasury Department, in connection with functions transferred under this
reorganization plan, were transferred to the Justice Department.
The Bureau of Narcotics and Dangerous Drugs, including the office of
Director thereof, in the Department of Justice was abolished by Reorg.
Plan No. 2 of 1973, eff. July 1, 1973, 38 F.R. 15932, 87 Stat. 1091, set
out in the Appendix to Title 5, Government Organization and Employees.
Reorg. Plan No. 2 of 1973 also created in the Department of Justice a
single, comprehensive agency for the enforcement of drug laws to be
known as the Drug Enforcement Administration, empowered the Attorney
General to authorize the performance by officers, employees, and
agencies of the Department of functions transferred to him, and directed
the Attorney General to coordinate all drug law enforcement functions to
assure maximum cooperation between the Drug Enforcement Administration,
the Federal Bureau of Investigation, and the other units of the
Department of Justice involved in drug law enforcement.
